ACP
BIIB icon

Ashfield Capital Partners’s Biogen BIIB Stock Holding History

Ashfield Capital Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,019
Closed -$241K – 244
2019
Q1 		$241K Sell
1,019
-368
-27% -$116K 0.03% 232
2018
Q4 		$417K Buy
1,387
+368
+36% +$117K 0.05% 184
2018
Q3 		$360K Hold
1,019
– – 0.04% 210
2018
Q2 		$296K Sell
1,019
-864
-46% -$243K 0.04% 227
2018
Q1 		$516K Sell
1,883
-285
-13% -$88.5K 0.07% 192
2017
Q4 		$691K Sell
2,168
-124
-5% -$39.8K 0.09% 167
2017
Q3 		$718K Sell
2,292
-120
-5% -$35.5K 0.1% 163
2017
Q2 		$655K Sell
2,412
-9,252
-79% -$2.45M 0.09% 169
2017
Q1 		$3.19M Sell
11,664
-15,606
-57% -$4.41M 0.44% 71
2016
Q4 		$7.73M Sell
27,270
-9,854
-27% -$2.92M 0.76% 46
2016
Q3 		$11.6M Sell
37,124
-2,138
-5% -$633K 0.96% 37
2016
Q2 		$9.49M Sell
39,262
-4,439
-10% -$1.17M 0.76% 43
2016
Q1 		$11.4M Buy
43,701
+1,363
+3% +$360K 0.82% 43
2015
Q4 		$13M Sell
42,338
-39,097
-48% -$11.2M 0.89% 41
2015
Q3 		$23.8M Sell
81,435
-12,284
-13% -$4.06M 1.53% 19
2015
Q2 		$37.9M Sell
93,719
-2,308
-2% -$926K 2.08% 6
2015
Q1 		$40.5M Sell
96,027
-19,102
-17% -$7.53M 2.16% 7
2014
Q4 		$39.1M Buy
115,129
+19,980
+21% +$6.46M 1.89% 11
2014
Q3 		$31.5M Buy
95,149
+44,270
+87% +$14.6M 1.53% 21
2014
Q2 		$16M Buy
+50,879
New +$15.3M 0.75% 50

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ashfield Capital Partners's BIIB Position: Q2 2019 in Review

Ashfield Capital Partners sold out of Biogen (BIIB) in Q2 2019, closing a stake of 1,019 shares — an estimated $241K sold.

Ashfield Capital Partners first reported a position in BIIB in Q2 2014 and held it in 20 quarters. The position peaked at $40.5M in Q1 2015. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Ashfield Capital Partners reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Ashfield Capital Partners sold 1,019 Biogen shares in Q2 2019, an estimated $241K.
  • Ashfield Capital Partners first reported a position in Biogen in Q2 2014 and held it in 20 quarters.
  • Ashfield Capital Partners's Biogen position peaked at $40.5M in Q1 2015.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Ashfield Capital Partners's 13F filing for Q2 2019, filed 29 Jul 2019.